[Federal Register Volume 85, Number 92 (Tuesday, May 12, 2020)]
[Notices]
[Pages 28022-28023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10126]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel;

[[Page 28023]]

Exploring Epigenomic or Non-Coding RNA Regulation in the 
Development, Maintenance or Treatment of Chronic Pain (R61/R33).
    Date: May 27, 2020.
    Time: 12:00 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Drug Abuse, NIH, Neurosciences 
Center Building, 6001 Executive Boulevard, Rockville, MD 20852 
(Telephone Conference Call).
    Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review 
Officer, Office of Extramural Policy And Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, 6001 
Executive Boulevard, Room 4228, MSC 9550, Bethesda, MD 20892, (301) 
827-4471, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Contract Review for ``Clinical Research Coordinating 
Center for NIDA's Clinical Trials Network.''
    Date: June 4, 2020.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute on Drug Abuse, NIH, Neurosciences 
Center Building, 6001 Executive Boulevard, Rockville, MD 20852 
(Telephone Conference Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, Division of Extramural Research, 
National Institute on Drug Abuse, NIH, 6001 Executive Boulevard, 
Room 4238, MSC 9550, Bethesda, MD 20892, (301) 402-6020, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: May 7, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-10126 Filed 5-11-20; 8:45 am]
BILLING CODE 4140-01-P